Surgical outcomes after cytoreductive nephrectomy with inferior vena cava thrombectomy

Urology

Volumn 84, Issue 6, 2014, Pages 1414-1419

  Westesson, Karin E ^a   Klink, Joseph C ^a   Rabets, John C ^a   Fergany, Amr F ^a   Klein, Eric A ^a   Stephenson, Andrew J ^a   Rini, Brian I ^a   Navia, Jose ^a   Krishnamurthi, Venkatesh ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL METASTASIS; ADULT; ARTICLE; BONE METASTASIS; BRAIN HYPOXIA; BRAIN INJURY; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DEEP VEIN THROMBOSIS; DIAPHRAGM INJURY; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FOLLOW UP; HUMAN; INFERIOR CAVA VEIN; INFERIOR CAVA VEIN THROMBUS; INTESTINE INJURY; KIDNEY CARCINOMA; LIVER INJURY; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; MEDICAL RECORD REVIEW; MOLECULARLY TARGETED THERAPY; MULTIPLE CANCER; MULTIPLE ORGAN FAILURE; MUSCLE METASTASIS; NEPHRECTOMY; PEROPERATIVE COMPLICATION; PLEURA EFFUSION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETROPERITONEAL CANCER; SMALL INTESTINE OBSTRUCTION; SPLEEN INJURY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL TIME; SYSTEMIC THERAPY; THROMBECTOMY; TREATMENT OUTCOME; TUMOR EMBOLISM; TUMOR THROMBUS; VEIN EMBOLISM; AGED; CARCINOMA, RENAL CELL; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; KIDNEY NEOPLASMS; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PARASITOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY; SURGERY; SURVIVAL RATE;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; NEPHRECTOMY; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; THROMBECTOMY; TREATMENT OUTCOME; VENA CAVA, INFERIOR;

EID: 84922482095     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.05.078     Document Type: Article

References (29)

1. A.C. Reese, J.M. Whitson, and M.V. Meng Natural history of untreated renal cell carcinoma with venous tumor thrombus Urol Oncol 31 2012 1305 1309
2. J.M. Whitson, A.C. Reese, and M.V. Meng Factors associated with surgery in patients with renal cell carcinoma and venous tumor thrombus BJU Int 107 2011 729 734
3. R.C. Flanigan, S.E. Salmon, and B.A. Blumenstein et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 2001 1655 1659
4. G.H. Mickisch, A. Garin, and H. van Poppel et al. European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Lancet 358 2001 966 970
5. L. Zini, U. Capitanio, and P. Perrotte et al. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma Urology 73 2009 342 346
6. J.W. Slaton, M. Derya Balbay, and D.A. Levy et al. Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma Eur Urol 50 1997 673 677
7. J. Naitoh, A. Kaplan, and F. Dorey et al. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy J Urol 162 1999 46 50
8. R.J. Neves, and H. Zincke Surgical treatment of renal cancer with vena cava extension Br J Urol 59 1987 390 395
9. V.S. Subramanian, A.J. Stephenson, and D.A. Goldfarb et al. Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi Urology 74 2009 154 159
10. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
11. R.J. Motzer, J. Bacik, and T. Mariani et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology J Clin Oncol 20 2002 2376 2381
12. B.I. Rini, J. Garcia, and P. Elson et al. The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery J Urol 187 2012 1548 1554
13. A. Zisman, A.J. Pantuck, and D.H. Chao et al. Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate? J Urol 168 2002 962 967
14. M.A. Goetzl, E.T. Goluboff, and A.M. Murphy et al. A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survival Urol Oncol 22 2004 182 187
15. M. Staehler Kidney cancer: the role of metastasectomy in metastatic renal cell carcinoma Nat Rev Urol 8 2011 180 181
16. J.M. Whitson, A.C. Reese, and M.V. Meng Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus Urol Oncol 31 2013 259 263
17. M.L. Blute, B.C. Leibovich, and C.M. Lohse et al. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus BJU Int 94 2004 33 41
18. J.B. Dimick, P.J. Pronovost, J.A. Cowan, and P.A. Lipsett Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg 75 2003 337 341
19. W.C. Schroer, G.T. Calvert, and P.J. Diesfeld et al. Effects of increased surgical volume on total knee arthroplasty complications J Arthroplasty 23 6 Suppl 1 2008 61 67
20. J.L.J. Navia, N.A.N. Brozzi, and E.R.E. Nowicki et al. Simplified perfusion strategy for removing retroperitoneal tumors with extensive cavoatrial involvement J Thorac Cardiovasc Surg 143 2012 1014 1021
21. B. Shuch, S.B. Riggs, and J.C. LaRochelle et al. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm BJU Int 102 2008 692 696
22. P.I.P. Karakiewicz, N.N. Suardi, and C.C. Jeldres et al. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi Eur Urol 53 2008 845 848
23. G. Robert, G. Gabbay, and R. Bram et al. Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma Eur Urol 55 2009 1477 1480
24. A. Bex, A.A. Van der Veldt, and C. Blank et al. Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib Acta Oncol 49 2010 520 523
25. N.G. Cost, S.E. Delacroix, and J.P. Sleeper et al. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus Eur Urol 59 2011 912 918
26. R.J. Motzer, T.E. Hutson, and P. Tomczak et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 2007 115 124
27. B. Escudier, T. Eisen, and W.M. Stadler et al. Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 2007 125 134
28. C.N. Sternberg, I.D. Davis, and J. Mardiak et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial J Clin Oncol 28 2010 1061 1068
29. A.L. Alt, S.A. Boorjian, and C.M. Lohse et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma Cancer 117 2011 2873 2882